Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-21

Clinical Trial Update: The Breakfast Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial sponsored by the University of Michigan for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: COMPLETED